Yosef S. Haviv

2.3k total citations
87 papers, 1.6k citations indexed

About

Yosef S. Haviv is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Yosef S. Haviv has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Oncology and 21 papers in Genetics. Recurrent topics in Yosef S. Haviv's work include Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (9 papers) and CAR-T cell therapy research (8 papers). Yosef S. Haviv is often cited by papers focused on Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (9 papers) and CAR-T cell therapy research (8 papers). Yosef S. Haviv collaborates with scholars based in Israel, United States and Germany. Yosef S. Haviv's co-authors include David T. Curiel, Rifaat Safadi, Tomer Avraham, Babak J. Mehrara, Alan Yan, Stanley G. Rockson, Sanjay V. Daluvoy, Jerry L. Blackwell, Minghui Wang and Constantin Reinus and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Yosef S. Haviv

86 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yosef S. Haviv Israel 22 520 459 389 298 254 87 1.6k
An‐Hang Yang Taiwan 23 491 0.9× 314 0.7× 98 0.3× 379 1.3× 314 1.2× 75 1.7k
Barry Skikne United States 29 550 1.1× 234 0.5× 140 0.4× 218 0.7× 87 0.3× 105 3.7k
Fong‐Fu Chou Taiwan 30 571 1.1× 498 1.1× 260 0.7× 1.1k 3.5× 486 1.9× 135 2.8k
Andreas Kapsoritakis Greece 25 274 0.5× 314 0.7× 539 1.4× 609 2.0× 85 0.3× 66 1.7k
Stanislas Faguer France 28 701 1.3× 265 0.6× 390 1.0× 531 1.8× 657 2.6× 133 2.5k
Jöelle Bernheim Israel 23 192 0.4× 241 0.5× 143 0.4× 359 1.2× 166 0.7× 88 1.7k
Mark Roest Netherlands 30 301 0.6× 187 0.4× 152 0.4× 384 1.3× 202 0.8× 118 3.0k
A R Morley United Kingdom 25 350 0.7× 161 0.4× 191 0.5× 355 1.2× 260 1.0× 86 1.7k
Stanley M. Naguwa United States 26 305 0.6× 190 0.4× 156 0.4× 320 1.1× 171 0.7× 46 2.2k
Fatma Gümrük Türkiye 23 366 0.7× 179 0.4× 229 0.6× 170 0.6× 62 0.2× 200 2.0k

Countries citing papers authored by Yosef S. Haviv

Since Specialization
Citations

This map shows the geographic impact of Yosef S. Haviv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosef S. Haviv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosef S. Haviv more than expected).

Fields of papers citing papers by Yosef S. Haviv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosef S. Haviv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosef S. Haviv. The network helps show where Yosef S. Haviv may publish in the future.

Co-authorship network of co-authors of Yosef S. Haviv

This figure shows the co-authorship network connecting the top 25 collaborators of Yosef S. Haviv. A scholar is included among the top collaborators of Yosef S. Haviv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosef S. Haviv. Yosef S. Haviv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, Eyal, et al.. (2023). Can Dialysis Patients Identify and Diagnose Pulmonary Congestion Using Self-Lung Ultrasound?. Journal of Clinical Medicine. 12(11). 3829–3829. 9 indexed citations
2.
Rogachev, Boris, Reut Riff, Endre Z. Neulander, et al.. (2023). Blockade of sodium–glucose co-transporters improves peritoneal ultrafiltration in uraemic rodent models. Peritoneal Dialysis International. 44(1). 48–55. 4 indexed citations
3.
Greenberg, Dan, et al.. (2021). The impact of gender on early scientific publication and long-term career advancement in Israeli medical school graduates. BMC Medical Education. 21(1). 163–163. 5 indexed citations
4.
Abuhasira, Ran, Yosef S. Haviv, Merav Leiba, et al.. (2021). Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study. European Journal of Internal Medicine. 86. 79–85. 17 indexed citations
5.
6.
Einbinder, Yael, Alla Shnaider, Boris Rogachev, et al.. (2020). Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality. American Journal of Nephrology. 51(11). 852–860. 10 indexed citations
7.
Shahar, Danit R., et al.. (2018). Determinants of ESRD patients’ nutritional status and their dietary intake quality, should we re-consider some recommendations?. Clinical Nutrition. 37. S238–S238. 1 indexed citations
8.
Sagy, Iftach, Yosef S. Haviv, Anat Rabinovich, et al.. (2018). Dabigatran-induced nephropathy and its successful treatment with Idarucizumab - case report and literature review. Thrombosis Research. 169. 120–122. 13 indexed citations
9.
Gorodetsky, Raphael, et al.. (2009). An in-vitro tumour microenvironment model using adhesion to type I collagen reveals Akt-dependent radiation resistance in renal cancer cells. Nephrology Dialysis Transplantation. 25(2). 373–380. 16 indexed citations
10.
Boudville, Neil, Ognjenka Djurdjev, Iain C. Macdougall, et al.. (2009). Hemoglobin Variability in Nondialysis Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 4(7). 1176–1182. 38 indexed citations
11.
Bendayan, Moı̈se, Diane Gingras, Ehud Ziv, & Yosef S. Haviv. (2008). Low‐voltage transmission electron microscopy reveals SV40 viral particles within secretory granules in pancreatic cells. Microscopy Research and Technique. 71(9). 659–662. 3 indexed citations
12.
Houdt, Winan J. van, Hongju Wu, Joel N. Glasgow, et al.. (2007). Gene delivery into malignant glioma by infectivity-enhanced adenovirus: In vivo versus in vitro models. Neuro-Oncology. 9(3). 280–290. 7 indexed citations
13.
Kolodkin‐Gal, Dror, et al.. (2006). A novel system to study adenovirus tropism to normal and malignant colon tissues. Virology. 357(1). 91–101. 15 indexed citations
14.
Houdt, Winan J. van, Yosef S. Haviv, Baogen Lu, et al.. (2006). The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma. Journal of neurosurgery. 104(4). 583–592. 69 indexed citations
15.
Breidenbach, Martina, Daniel Rein, Thomas Schöndorf, et al.. (2005). A new targeting approach for breast cancer gene therapy using the Heparanase promoter. Cancer Letters. 240(1). 114–122. 17 indexed citations
16.
Haviv, Yosef S. & David T. Curiel. (2003). Engineering Regulatory Elements for Conditionally-Replicative Adenoviruses. Current Gene Therapy. 3(4). 357–385. 21 indexed citations
17.
Haviv, Yosef S., et al.. (2000). HYPOGLYCEMIA IN PATIENTS WITH RENAL FAILURE. Renal Failure. 22(2). 219–223. 52 indexed citations
18.
Gare, Meir, Yosef S. Haviv, Tali Bdolah‐Abram, et al.. (1999). The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. Journal of the American College of Cardiology. 34(6). 1682–1688. 87 indexed citations
19.
Friedlaender, Michael M., Yosef S. Haviv, E. Rosenmann, & Nili Peylan‐Ramu. (1998). End-Stage Renal Interstitial Fibrosis in an Adult Ten Years after Ifosfamide Therapy. American Journal of Nephrology. 18(2). 131–133. 18 indexed citations
20.
Safadi, Rifaat, et al.. (1997). Primary Non-Hodgkin's Lymphoma of the Lung Presenting as Bronchiolitis Obliterans Organizing Pneumonia. Leukemia & lymphoma. 28(1-2). 209–213. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by An‐Hang Yang Breakdown of academic impact, for papers by Barry Skikne Breakdown of academic impact, for papers by Fong‐Fu Chou Breakdown of academic impact, for papers by Andreas Kapsoritakis Breakdown of academic impact, for papers by Stanislas Faguer Breakdown of academic impact, for papers by Jöelle Bernheim Breakdown of academic impact, for papers by Mark Roest Breakdown of academic impact, for papers by A R Morley Breakdown of academic impact, for papers by Stanley M. Naguwa Breakdown of academic impact, for papers by Fatma Gümrük
Rankless by CCL
2026